08048035996
Zyceva 150 mg Good Quality Tablets to UK - Birmingham | Phoenix Exim | Trusted Exporter

1. General Information

Zyceva 150 mg Tablet is an anti-cancer medicine belonging to the tyrosine kinase inhibitor (TKI) class. Its active ingredient, erlotinib, works by blocking epidermal growth factor receptor (EGFR) signaling, which can contribute to the growth and multiplication of certain cancer cells.

It is a prescription-only medicine and should be used only under the supervision of an oncologist or qualified healthcare professional.

2. Product Information

  • Brand: Zyceva 150 mg Tablet
  • Active Ingredient: Erlotinib
  • Strength: 150 mg
  • Dosage Form: Tablet
  • Therapeutic Category: Antineoplastic / targeted cancer therapy
  • Route: Oral
  • Manufacturer/Marketer: Zydus
  • Typical Pack: 30 tablets, depending on market and packaging
  • Storage: Store below 30°C and protect the medicine according to the manufacturer's packaging instructions.

3. Uses of Zyceva 150 mg Tablet

Zyceva 150 mg may be prescribed for:

  • Non-small-cell lung cancer (NSCLC), particularly when the cancer has appropriate molecular characteristics such as EGFR-related disease.
  • Advanced pancreatic cancer, where erlotinib may be used in combination with other anticancer treatment in selected patients.

The exact indication depends on the patient's cancer type, stage, molecular profile, previous treatment and oncologist's treatment plan.

4. Benefits of Zyceva 150 mg Tablet

Zyceva provides targeted inhibition of EGFR signaling. In cancers that depend on EGFR signaling, blocking this pathway can help slow cancer-cell growth and proliferation. For appropriate patients, this may help control disease progression.

The medicine is not a general cancer treatment and its potential benefit depends on the specific cancer and clinical characteristics of the patient.

5. Side Effects of Zyceva 150 mg Tablet

Possible side effects include:

  • Diarrhea
  • Skin rash
  • Abdominal/stomach pain
  • Nausea
  • Vomiting
  • Fatigue
  • Cough
  • Breathlessness
  • Muscle or bone pain
  • Fever
  • Infection
  • Mouth inflammation (stomatitis)
  • Weight loss

Some uncommon but potentially serious reactions can involve the lungs, liver, eyes, skin, or gastrointestinal tract. Seek medical attention promptly if severe or unusual symptoms develop.

6. Common Side Effects

The commonly reported side effects include:

  1. Skin rash
  2. Diarrhea
  3. Abdominal pain
  4. Fatigue/tiredness
  5. Nausea
  6. Vomiting
  7. Cough
  8. Weight loss
  9. Mouth sores/inflammation

Patients should not discontinue cancer treatment on their own because of side effects; the treating doctor can determine whether supportive treatment or dose adjustment is required.

7. How to Use Zyceva 150 mg Tablet

  • Take Zyceva exactly as prescribed by your oncologist.
  • It is generally taken once daily.
  • Take it on an empty stomach, at least 1 hour before or 2 hours after food.
  • Swallow the tablet whole with water.
  • Do not crush, chew or break it unless specifically instructed by your healthcare professional.
  • Try to take it at approximately the same time each day.

Do not change the dose or stop treatment without consulting your doctor.

8. How Zyceva 150 mg Works

Zyceva contains erlotinib, which is a tyrosine kinase inhibitor. Erlotinib blocks the activity of epidermal growth factor receptor (EGFR).

EGFR signaling can send signals that encourage certain cancer cells to grow and multiply. By inhibiting this signaling pathway, erlotinib can help slow or inhibit the growth and spread of susceptible cancer cells.

9. Safety Advice

Pregnancy: Erlotinib can potentially harm an unborn baby. Women who can become pregnant should discuss effective contraception with their healthcare professional.

Breastfeeding: Discuss breastfeeding with your doctor before treatment.

Smoking: Tobacco smoking can increase the body's clearance of erlotinib and may reduce its effectiveness. Tell your doctor if you smoke or stop smoking during treatment.

Sun exposure: Erlotinib may cause or worsen skin reactions. Protect the skin from excessive sunlight and follow your doctor's advice regarding sunscreen and protective clothing.

Stomach-acid medicines: Some antacids and acid-reducing medicines can affect erlotinib absorption. Tell your doctor or pharmacist about all medicines you take before starting treatment.

Liver problems: Tell your doctor if you have liver disease or develop symptoms such as yellowing of the skin or eyes.

Lung symptoms: Report new or worsening cough, breathlessness or difficulty breathing promptly because serious lung complications can occur rarely.

Prescription status: Zyceva should be supplied and used according to applicable prescription and pharmaceutical regulations.

10. Frequently Asked Questions (FAQs)

Q1. What is Zyceva 150 mg used for?
Zyceva 150 mg contains erlotinib and is used for certain types of non-small-cell lung cancer and, in selected treatment regimens, advanced pancreatic cancer.

Q2. Is Zyceva 150 mg a chemotherapy medicine?
It is an anticancer medicine but is not conventional cytotoxic chemotherapy. It is a targeted tyrosine kinase inhibitor that acts on EGFR signaling.

Q3. Should Zyceva be taken with food?
It is generally taken on an empty stomach—at least 1 hour before or 2 hours after food.

Q4. Can I stop Zyceva if I feel better?
No. Cancer treatment should be continued or stopped only according to the treating oncologist's instructions.

Q5. What happens if I develop a skin rash?
Rash is a common side effect. Inform your healthcare professional, particularly if the rash is severe, painful, blistering or accompanied by other concerning symptoms.

Q6. Can Zyceva interact with other medicines?
Yes. Erlotinib has clinically important drug interactions, including with some acid-reducing medicines and other medicines that affect its metabolism. Provide your doctor with a complete list of medicines and supplements you use.

11. Substitutes for Zyceva 150 mg

Because substitutes contain the same active ingredient but may differ in manufacturer, formulation, availability and regulatory status, they should be selected by a healthcare professional.

Examples of erlotinib 150 mg brands listed as alternatives include:

  • Erlonat 150 Tablet
  • Erleva 150 mg Tablet
  • Erlokem 150 mg Tablet
  • Erlot 150 mg Tablet
  • Tarceva 150 mg Tablet

Important: Do not switch between brands or cancer medicines without approval from the treating oncologist.

12. SEO Keywords

  • Zyceva 150 mg Tablet exporter
  • Zyceva 150 mg Tablet supplier from India
  • Zyceva 150 mg Erlotinib exporter
  • Zyceva 150 mg wholesale supplier
  • Erlotinib 150 mg Tablet exporter India
  • Erlotinib 150 mg pharmaceutical supplier
  • Zyceva 150 mg medicine exporter from Nagpur
  • Zyceva 150 mg cancer medicine supplier
  • Zyceva 150 mg anti cancer tablet exporter
  • Zyceva 150 mg oncology medicine supplier
  • Buy Zyceva 150 mg for pharmaceutical procurement
  • Zyceva 150 mg B2B pharmaceutical supplier
  • Zyceva 150 mg bulk medicine supplier
  • Erlotinib 150 mg bulk supplier India
  • Zyceva 150 mg international pharmaceutical supplier
  • Zyceva 150 mg exporter to USA
  • Zyceva 150 mg exporter to UK
  • Zyceva 150 mg exporter to Australia
  • Zyceva 150 mg exporter to Singapore
  • Zyceva 150 mg exporter to Canada
  • Zyceva 150 mg exporter to South Korea
  • Zyceva 150 mg exporter to UAE
  • Erlotinib 150 mg exporter USA
  • Erlotinib 150 mg exporter UK
  • Erlotinib 150 mg exporter Australia
  • Erlotinib 150 mg exporter Canada
  • Erlotinib 150 mg exporter UAE
  • Indian pharmaceutical exporter Nagpur
  • Phoenix Exim pharmaceutical exporter
  • Phoenix Exim medicine supplier India
  • Phoenix Exim oncology medicine exporter
  • Phoenix Exim Erlotinib supplier
  • Phoenix Exim Zyceva 150 mg supplier
Aug 14th, 2026 3:28 PM

Keywords